Point-of-Care Testing in Hemostasis

Quality in Laboratory Hemostasis and Thrombosis

Volumn , Issue , 2009, Pages 72-80

  Gardiner, C ^a   Machin, S ^a,b   Mackie, I ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Activated partial thromboplastin time testing; Oral anticoagulant therapy (OAT); Oral anticoagulation monitoring; Patient self monitoring of oral anticoagulation; POCT device for monitoring low molecular weight heparin (LMWH); Point of care testing (POCT) and near patient testing (NPT); Quality assurance of point of care INR monitors; Suitable quality control (QC) system to ensure validity of results; Thrombelastograph TEG ROTEM in cardiac surgery and liver transplant procedures

Indexed keywords

EID: 70349935395     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303575.ch8     Document Type: Chapter

References (29)

1. Harrison P. Platelet function analysis. Blood Rev 2005; 19: 111-123.
2. Baglin TP, Cousins D, Keeling DM, et al. Recommendations from the British Committee for Standards In Haematology and National Patient Safety Agency. Br J Haematol 2006; 136: 26-29.
3. Gregoratos G. Perspectives. Oral anticoagulant therapy: current issues. Prev Cardiol 2000; 3: 178-182.
4. Fitzmaurice DA. Oral anticoagulation control: the European perspective. J Thromb Thrombolysis 2006; 21: 95-100.
5. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102.
6. Gardiner C, Williams K, Mackie IJ, et al. Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. Clin Lab Haematol 2006; 28: 122-125.
7. Fitzmaurice DA, Murray ET, McCahon D, et al. Self management of oral anticoagulation: randomised trial. BMJ 2005; 331: 1057.
8. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: a randomized, controlled trial. Ann Intern Med 2000; 133: 687-695.
9. Machin SJ, Mackie IJ, Chitolie A, et al. Near patient testing (NPT) in haemostasis: a synoptic review. Clin Lab Haematol 1996; 18: 69-74.
10. Moriarty HT, Lam-Po-Tang PR, Anastas N. Comparison of thromboplastins using the ISI and INR system. Pathology 1990; 22: 71-76.
11. British Committee for Standards in Haematology. Guidelines on oral anticoagulation, third edition. Br J Haematol 1998; 101: 374-387.
12. Baglin TP, Keeling DM, Watson HG. for the British Committee for Standards in Haematology. Guidelines on oral anticoagulation (warfarin): third edition -2005 update. Br J Haematol 2005; 132: 277-285.
13. Gardiner C, Adcock DM, Carrington LR, et al. Protocol for the Evaluation, Validation and Implementation of Coagulometers; Proposed Guideline. CLSI: 2007. H57-P.
14. Solvik UO, Stavelin A, Christensen NG, et al. External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with CHAPTER 8 80 commercial control material. Scand J Clin Lab Invest 2006; 66: 337-349.
15. Kitchen DP, Murray ET, Jennings I, et al. Comparison of Coaguchek S INRs with hospital laboratory citrated plasma INRs. What is the truth? Br J Haematol 2005; 129 (Suppl. 1): 18.
16. Gardiner C, Williams K, Longair I, et al. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. Br J Haematol 2005; 132: 598-603.
17. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411.
18. Fitzmaurice DA, Gardiner C, Kitchen S, et al. An evidence- based review and guidelines for patient self-testing and management of oral anticoagulation. Br J Haematol 2005; 131: 156-165.
19. Ansell J, Jacobson A, Levy J, et al. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 2005; 99: 37-45.
20. Ferring M, Reber G, de Moerloose P, et al. Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients. Can J Anaesth 2001; 48: 1155-1160.
21. Choi TS, Greilich PE, Shi C, et al. Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery. Am J Clin Pathol 2002; 117: 74-78.
22. Despotis GJ, Gravlee G, Filos K, et al. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 1999; 91: 1122-1151.
23. Despotis GJ, Filos KS, Levine V, et al. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro. Anesth Analg 1996; 82: 1126-1131.
24. El Rouby S, Cohen M, Gonzales A, et al. The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures. J Thromb Thrombolysis 2006; 21: 137-145.
25. Heim SW, Schectman JM, Siadaty MS, et al. d-dimer testing for deep venous thrombosis: a metaanalysis. Clin Chem 2004; 50: 1136-1147.
26. Hartert H. Blutgerrinungsstudien mit der thrombelastographie, einem neuen untersuchungsverfahren. Klin Wochenschr 1948; 26: 577-583.
27. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992; 69: 307-313.
28. Luddington RJ. Thrombelastography/thrombelastometry. Clin Lab Haematol 2005; 27: 81-90.
29. Briggs C, Guthrie D, Hyde K, et al. Guidelines for Point of Care Testing: Hematology. British Committee for Standards in Haematology (BCSH) General Haematology Task Force: 2007. http://www.bcshguidelines.com/ pdf/POCT_guidelines_310707.pdf QC, quality control.